Hemostatic agent use in heart and blood vessel surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a cardiac or vascular surgeon at IRCCS Galeazzi-Sant'Ambrogio in Milan.
- You have performed heart or blood vessel surgery in the last year.
- You work at the study hospital and agree to fill out an anonymous survey.
- You are not a nurse, anesthesiologist, or other non-surgical staff.
- You are willing to answer questions about surgical cases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new hemostatic agent called ETHIZIA against the standard SURGICEL Original to see if it works better at stopping bleeding from soft tissues during planned open surgeries. If you need a more effective way to control bleeding during your procedure, this study might help.
This study examines how heart-lung machines used during heart surgery affect blood platelets (clotting cells) and the body's inflammatory response. Understanding these changes may help doctors better manage bleeding and inflammation after cardiac surgery.
This trial tests if a machine that collects and reuses blood during heart surgery can help patients avoid needing donor blood transfusions. It is for people having a first-time coronary bypass or heart valve surgery.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This trial is looking at how different anesthesia, perfusion, and surgery methods affect people having heart surgery. It aims to improve care for heart surgery patients by studying current practices.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
Hear when a new Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.